Sector pending / Surgical and Medical Instruments and ApparatusUpdated 2026-05-10 22:07 UTC

FRA/L8B stock hub

FRA/L8B has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/L8Bis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

480.7M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/L8BFRA/L8B

—

Loading chart…

In the news

Latest news · FRA/L8B

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E9.4

P25 n/aP50 n/aP75 n/a

ROE14.9

P25 n/aP50 n/aP75 n/a

ROIC16.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/L8B market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

205

Groups with data

Currency

JPY

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	DE
Employees	1,250
Employees Change	34%
Employees Change Percent	2.8
Enterprise value	EUR 429.5M
Exchange	Frankfurt Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Surgical and Medical Instruments and Apparatus
Last refreshed	2026-05-10
Market cap	EUR 480.7M
Price	EUR 7.5
Price currency	EUR
Rev Per Employee	258,270.52x
Sic	3841
Symbol	fra/L8B
Website	https://www.japanlifeline.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.61%
EV Earnings	8.42x
EV/EBIT	6.29x
EV/EBITDA	5.44x
EV/FCF	12.55x
EV/Sales	1.34x
FCF yield	7.12%
P/B ratio	1.34x
P/E ratio	9.42x
P/S ratio	1.49x
PE Ratio10 Y	19.52x
PE Ratio3 Y	11.37x
PE Ratio5 Y	13.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.26%
EBITDA Margin	24.59%
FCF margin	10.6%
Gross margin	59.43%
Gross Profit	EUR 191.9M
Gross Profit Growth	2.88%
Gross Profit Growth Q	8.14%
Gross Profit Growth3 Y	5.57%
Gross Profit Growth5 Y	4.18%
Net Income	EUR 51M
Net Income Growth	0.35%
Net Income Growth Q	12.6%
Net Income Growth3 Y	10.71%
Net Income Growth5 Y	36.13%
Pretax Margin	20.91%
Profit Margin	15.8%
Profit Per Employee	EUR 40,800
ROA	10.13
Roa5y	9.46
ROCE	18.89
ROE	14.86
Roe5y	14.08
ROIC	16.64
Roic5y	16.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-17.83%
EPS Growth	1.41
EPS Growth Q	12.47
EPS Growth3 Y	14.75
EPS Growth5 Y	39.87
FCF Growth	-17.07%
FCF Growth3 Y	-16.4%
FCF Growth5 Y	-9.68%
OCF Growth	-10.33%
OCF Growth10 Y	24.46%
OCF Growth3 Y	-9.98%
OCF Growth5 Y	-6.49%
Revenue Growth	4.55x
Revenue Growth Q	7.12x
Revenue Growth3 Y	4.58x
Revenue Growth5 Y	2.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.76
Assets	EUR 437.5M
Cash	EUR 68.1M
Current Assets	EUR 265.5M
Current Liabilities	EUR 73.6M
Debt	EUR 16.7M
Debt EBITDA	EUR 0.21
Debt Equity	EUR 0.05
Debt FCF	EUR 0.49
Equity	EUR 359.4M
Interest Coverage	370.1
Liabilities	EUR 78.1M
Long Term Assets	EUR 172M
Long Term Liabilities	EUR 4.5M
Net Cash	EUR 51.4M
Net Cash By Market Cap	EUR 10.7
Net Cash Growth	31.29%
Net Debt EBITDA	EUR -0.65
Net Debt Equity	EUR -0.14
Net Debt FCF	EUR -1.5
Tangible Book Value	EUR 350.9M
Tangible Book Value Per Share	EUR 5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.61
Inventory Turnover	1.26
Net Working Capital	EUR 141M
Quick ratio	1.99
Working Capital	EUR 193.4M
Working Capital Turnover	EUR 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.04%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	EUR 0.29
Dividend Years	2
Dividend Yield	3.9%
Ex Div Date	2026-03-30
Last Dividend	EUR 0.29
Payout Frequency	Annual
Payout Ratio	39.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-17.82%
200-day SMA	8.06
50-day SMA	7.55
50-day SMA vs 200-day SMA	50under200
All Time High	9.93
All Time High Change	-24.5%
All Time High Date	2025-02-11
All Time Low	6.7
All Time Low Change	11.94%
All Time Low Date	2026-05-08
ATR	0.16
Ch YTD	-10.34
High	7.5
High52	8.91
High52 Date	2025-06-12
High52ch	-21%
Low	7.5
Low52	6.7
Low52 Date	2026-05-08
Low52ch	4.17%
Ma50ch	-0.65%
Price vs 200-day SMA	-6.95%
RSI	32.85
RSI Monthly	18.23
RSI Weekly	33.09
Sharpe ratio	-0.83x
Sortino ratio	-0.83
Total Return	4.94%
Tr YTD	-6.73
Tr1m	-1.32%
Tr1w	3.45%
Tr3m	5.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 68.6M
Operating Income Growth	2.15
Operating Income Growth Q	26.36
Operating Income Growth3 Y	5.34
Operating Income Growth5 Y	5.04
Operating margin	21.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	47,273,723%
Net Borrowing	-3,897,057.3
Shares Insiders	30.64%
Shares Institutions	22.32%
Shares Qo Q	-0.01%
Shares Yo Y	-1.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 34.2M
Average Volume	227.5x
Bv Per Share	5.12
CAPEX	EUR -10.4M
Ch1m	-1.32
Ch1w	3.45
Ch1y	-21
Ch3m	1.71
Ch6m	-6.66
Change	0%
Change From Open	0
Close	7.5
Days Gap	0
Depreciation Amortization	10,668,194.4
Earnings Date	2026-05-07
EBIT	EUR 68.6M
EBITDA	EUR 79.4M
EPS	EUR 0.73
F Score	5
FCF	EUR 34.2M
FCF EV Yield	7.96x
Financing CF	-24,987,271
Fiscal Year End	March
Founded	1,981
Graham Number	10.021
Graham Upside	33.61
Income Tax	EUR 16.5M
Investing CF	-11,170,908
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	EUR 19.89
Lynch Upside	165.3
Ma150	7.96
Ma150ch	-5.73%
Ma20	7.38
Ma20ch	1.65%
Net CF	8,067,272
Open	7.5
P FCF Ratio	14.05
P OCF Ratio	10.78
Payment Date	2026-06-29
Ppne	75,294,394.8
Price Date	2026-05-07
Price EBITDA	EUR 6.05
Ptbv Ratio	1.37
Relative Volume	9.89x
Revenue	322,838,155x
Tax By Revenue	5.11x
Tax Rate	24.46%
Tr6m	-2.9%
Z Score	7.18

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/L8B dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.9%

$0.29 annual per share

Payout ratio

+39.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+4.9%

Next ex-dividend date: 2026-03-30

Performance

FRA/L8B stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/L8B?

Insider, institutional, and short-interest positioning.

Institutional ownership

+22.3%

Share of float held by funds and institutions

Insider ownership

+30.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.0%

Negative means the company is buying back shares.

Technical

FRA/L8B momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.8

Neutral momentum band

Price vs 200-day MA

-6.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.83

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/L8B

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/L8B stock rating?

fra/L8B is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/L8B analysis?

The full report lives at /stocks/fra/L8B/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/L8B?

The latest report frames fra/L8B around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/L8B page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.